Spremljaj
Niranjan J Sathianathen
Niranjan J Sathianathen
Preverjeni e-poštni naslov na student.unimelb.edu.au
Naslov
Navedeno
Navedeno
Leto
The state of the art in kidney and kidney tumor segmentation in contrast-enhanced CT imaging: Results of the KiTS19 challenge
N Heller, F Isensee, KH Maier-Hein, X Hou, C Xie, F Li, Y Nan, G Mu, ...
Medical image analysis 67, 101821, 2021
6162021
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
D Lobo, JM Devys
Anaesthesia 77 (1), 110, 2021
585*2021
The kits19 challenge data: 300 kidney tumor cases with clinical context, ct semantic segmentations, and surgical outcomes
N Heller, N Sathianathen, A Kalapara, E Walczak, K Moore, H Kaluzniak, ...
arXiv preprint arXiv:1904.00445, 2019
5382019
Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data …
NJ Sathianathen, A Omer, E Harriss, L Davies, V Kasivisvanathan, ...
European urology 78 (3), 402-414, 2020
3112020
Landmarks in prostate cancer
NJ Sathianathen, BR Konety, J Crook, F Saad, N Lawrentschuk
Nature Reviews Urology 15 (10), 627-642, 2018
1612018
Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis
NJ Sathianathen, S Koschel, IA Thangasamy, J Teh, O Alghazo, ...
European urology 77 (3), 365-372, 2020
1602020
Robotic assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis
NJ Sathianathen, A Kalapara, M Frydenberg, N Lawrentschuk, CJ Weight, ...
The Journal of urology 201 (4), 715-720, 2019
1512019
An international challenge to use artificial intelligence to define the state-of-the-art in kidney and kidney tumor segmentation in CT imaging.
N Heller, S McSweeney, MT Peterson, S Peterson, J Rickman, B Stai, ...
Journal of Clinical Oncology 38 (6_suppl), 626-626, 2020
1392020
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
C COVIDSurg, C GlobalSurg
Anaesthesia 77 (1), 28-39, 2022
1072022
A simplified frailty index to predict outcomes after radical cystectomy
NJ Sathianathen, S Jarosek, N Lawrentschuk, D Bolton, BR Konety
European urology focus 5 (4), 658-663, 2019
792019
Patterns‐of‐care and health economic analysis of robot‐assisted radical prostatectomy in the Australian public health system
M Basto, N Sathianathen, L Te Marvelde, S Ryan, J Goad, ...
BJU international 117 (6), 930-939, 2016
702016
Outcomes of artificial urinary sphincter implantation in the irradiated patient
NJ Sathianathen, SM McGuigan, DA Moon
BJU international 113 (4), 636-641, 2014
692014
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen …
A Amin, A Blazevski, J Thompson, MJ Scheltema, MS Hofman, D Murphy, ...
BJU international 125 (4), 515-524, 2020
672020
A cost-effectiveness analysis of systemic therapy for metastatic hormone-sensitive prostate cancer
NJ Sathianathen, F Alarid-Escudero, KM Kuntz, N Lawrentschuk, ...
European urology oncology 2 (6), 649-655, 2019
602019
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
NJ Sathianathen, YA Philippou, GM Kuntz, BR Konety, S Gupta, AD Lamb, ...
Cochrane Database of Systematic Reviews, 2018
582018
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
GS Collaborative, COVIDSurg Collaborative
The British journal of surgery 108 (9), 1056, 2021
572021
Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma
EC Hwang, NJ Sathianathen, JH Jung, MH Kim, P Dahm, MC Risk
Cochrane Database of Systematic Reviews, 2019
552019
The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis
NJ Sathianathen, M Butaney, BR Konety
World Journal of Urology 37, 1239-1249, 2019
542019
Cost-effectiveness analysis of active surveillance strategies for men with low-risk prostate cancer
NJ Sathianathen, BR Konety, F Alarid-Escudero, N Lawrentschuk, ...
European urology 75 (6), 910-917, 2019
522019
Incorporating biomarkers into the primary prostate biopsy setting: a cost-effectiveness analysis
NJ Sathianathen, KM Kuntz, F Alarid-Escudero, NL Lawrentschuk, ...
Journal of Urology 200 (6), 1215-1220, 2018
512018
Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.
Članki 1–20